We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BDTX market cap is 135.24M. The company's latest EPS is USD -1.4570 and P/E is -1.64.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.01M | -20.86M | -20.25M | -22.13M | -18.13M |
| Net Income | -23.01M | -19.41M | -18.23M | -19.91M | -15.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.33M | -69.57M | -126.87M | -95.08M | -86.46M |
| Net Income | -35.26M | -67.25M | -125.6M | -91.17M | -82.44M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 172.38M | 158.57M | 142.52M | 149.99M | 137.9M |
| Total Liabilities | 38.07M | 41.83M | 38.22M | 38.97M | 40.47M |
| Total Equity | 134.32M | 116.74M | 104.31M | 111.02M | 97.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 158.3M | 329.67M | 247.68M | 156.26M | 158.57M |
| Total Liabilities | 4.88M | 21.91M | 51.78M | 40.56M | 41.83M |
| Total Equity | -47.16M | 307.76M | 195.9M | 115.7M | 116.74M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.76M | -66.72M | -21.2M | -35.93M | -47.25M |
| Investing | 4.1M | 16.35M | -13.73M | -12.99M | -10.8M |
| Financing | 71.98M | 71.93M | 4.13M | 25.51M | 25.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.67M | -52.15M | -100.15M | -85.08M | -66.72M |
| Investing | -21k | -281.69M | 130.61M | 53.37M | 16.35M |
| Financing | 127.76M | 214.94M | 729k | 177k | 71.93M |
| Market Cap | 135.24M |
| Price to Earnings Ratio | -1.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.41 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 56.59M |
| Average Volume (1 week) | 860.37k |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | -17.01% |
| 52 Week High | 7.66 |
| 52 Week Low | 1.91 |
| Spread (Intraday) | 0.01 (0.42%) |
| Company Name | Black Diamond Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.blackdiamondtherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
